Johnson & Johnson
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
63/100
High Influence
$26.8M
Total Lobby Spend
7
Policy Issues
10
Lobbyists
2
Revolving Door
Johnson & Johnson reported $26.8 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 7 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Office of Management & Budget
Dept of Housing & Urban Development
Centers for Medicare & Medicaid Services
US Senate
Federal Communications Commission
Dept of Labor
US House of Representatives
Dept of Agriculture
Dept of Education
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Holland & Knight LLP | TRDHCRGOV+2 | 1 | $1.9M |
| 2020 Apr-Jun | Squire Patton Boggs LLP | CPTPHAGOV+1 | 3 | $1.4M |
| 2020 Jul-Sep | Brownstein Hyatt LLP | PHA | 4 | $1.6M |
| 2020 Oct-Dec | Brownstein Hyatt LLP | HCRPHATAX | 1 | $1.6M |
| 2021 Jan-Mar | BGR Group LLP | PHAHCR | 4 | $1.4M |
| 2021 Apr-Jun | Covington & Burling LLP | HCRPHAGOV+1 | 1 | $1.1M |
| 2021 Jul-Sep | Covington & Burling LLP | HCR | 4 | $1.4M |
| 2021 Oct-Dec | K&L Gates LLP | TRDMEDTAX | 3 | $1.5M |